Target intelligence / Profile preview

Dendritic cell plasma membrane

Molecular classification
Cellular component
01

Overview

The dendritic cell plasma membrane is the specialized lipid bilayer that defines the boundary of dendritic cells (DCs), the most potent antigen-presenting cells of the immune system [Banchereau & Steinman, 1998, Nature]. It serves as the primary platform for immune surveillance, housing a vast array of receptors such as Toll-like receptors (TLRs), C-type lectin receptors (CLRs), and Major Histocompatibility Complex (MHC) molecules [Worbs et al., 2017, Nature Reviews Immunology]. These surface proteins enable the capture, processing, and presentation of antigens to T cells, a process fundamental to the initiation of adaptive immunity. In clinical applications, the membrane is the site of action for various immunotherapies, including DC-based vaccines and checkpoint inhibitors that target membrane-bound proteins like PD-L1 [Gardner et al., 2020, Frontiers in Immunology]. Although the membrane itself is a complex cellular compartment rather than a single therapeutic target, its unique protein composition is critical for diagnosing immune states and developing targeted therapies for cancer and autoimmune diseases. The dynamic nature of this membrane allows for the formation of the immunological synapse, which is essential for effective T cell activation. Furthermore, the membrane's lipid composition and fluidity play roles in the efficiency of endocytosis and signaling.

Other names
DC plasma membraneDendritic cell surfaceDC surface membrane
02

Mechanism of action

Not applicable; the dendritic cell plasma membrane is a cellular structure containing multiple distinct molecular targets rather than being a single therapeutic target.

03

Biological functions

Antigen presentationImmune responseCell-cell signalingEndocytosisPathogen recognition
04

Disease associations

CancerInfectionAutoimmune diseaseInflammation
05

Safety considerations

Off-target immune stimulationCytokine release syndromeAutoimmune reactionsSystemic inflammatory response
06

Biomarkers

CD11c (Integrin alpha X)CD80 (B7-1)CD86 (B7-2)HLA-DR (MHC class II)CD1aCD83

Beyond the preview

Go deeper on Dendritic cell plasma membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dendritic cell plasma membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call